Preparing for the clinical development of the TOPK inhibitor OTS964
An individual drug development theme for the TOPK inhibitor OTS964, aimed at initiating clinical trials by advancing formulation studies and nonclinical studies following identification of the final compound.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.